INTRODUCTION
============

Bladder cancer is the 9^th^ most common malignancy and the 13^th^ leading cause of death worldwide [@B01]. It is primarily a disease of the elderly, with a median age of 72 years at diagnosis [@B02]. Radical cystectomy is the gold standard treatment for muscle-invasive or high-grade non-muscle-invasive bladder cancer [@B03]. With the development of the technique of minimally invasive surgery, Da Vinci robot-assisted radical cystectomy has become the primary and gold standard treatment for bladder cancer as it can better preserve nerve and vessels, which has been shown to reduce blood loss and transfusion, narcotic requirement, time to regular diet, and hospitalization days [@B03]--[@B05]. However, the use of robotic-assisted surgery usually increases the overall operating time and requires prolonged artificial pneumoperitoneum and some special patient positioning, which could affect the patient\'s pathophysiological conditions and easily induce perioperative hypothermia, especially in the elderly [@B06]. Intraoperative hypothermia can induce a series of perioperative complications, such as postoperative delayed wakefulness, shivering, coagulopathy, agitation, hypoxemia, poor wound healing, and headache [@B07]. It has been shown that intraoperative hypothermia is significantly associated with a higher short-term readmission rate and mortality in elderly patients [@B08]. Despite this, few studies exist on temperature management in Da Vinci robotic-assisted surgery.

Since infusing cold saline or packed red blood cells causes a marked decrease in patient\'s body temperature [@B09], pre-warmed infusions (to 38--42°C) is an important strategy to maintain intraoperative normothermia [@B10],[@B11]. The common methods of pre-warmed infusions include a double-wall infusion line and a fluid warming device [@B12],[@B13]. Intravenous fluids warming is one of the most effective strategies for intraoperatively maintaining normothermia [@B14],[@B15]. Intravenous fluid warming has been shown to effectively maintain the core temperature in laparoscopic colorectal surgery [@B16]. The Enhanced Recovery After Surgery (ERAS) Society guidelines for perioperative care after radical cystectomy for bladder cancer strongly recommend prevention of intraoperative hypothermia [@B17]. However, the beneficial effect of maintaining normothermia during radical cystectomy has not been evaluated[@B18]. Therefore, this study aimed to investigate the efficacy of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.

METHODS
=======

Participants and study design
-----------------------------

A total of 108 patients with bladder cancer scheduled to undergo DaVinci robotic-assisted laparoscopic radical cystectomy were recruited into this trial. Other inclusion criteria were American Society of Anesthesiologists (ASA) Score I-III and age 50-79 years. Patients with a history of cerebral infarction, mental abnormalities, preoperative urinary tract infection, or severe lung infection or disease were excluded. This study was approved by the institutional review board of our hospital and written informed consent was waived by the Institutional Review Board due to the retrospective nature of this study.

Fluid warming protocol
----------------------

Prior to the study, all nursing staff received training for the procedure of fluid warming and the data collection. The 108 enrolled patients were randomly divided into the control group (n=55) and the warming group (n=53). All patients underwent Da Vinci robot-assisted laparoscopic radical cystectomy at room temperature under the same anesthesia treatment.

In the warmed fluid group, all intraoperative fluids were administered via the Ranger™ Blood/Fluid Warming Unit (3M, St. Paul, MN, USA) using a setpoint of 41°C. The patients in the control group used a warming blanket (setpoint=43°C) during the intraoperative period.

Data collection
---------------

Demographic (sex, age) and baseline clinical characteristics (ASA score, Cardiac function (assessed by determining the ejection fraction), and body mass index \[BMI\]) were collected. Surgical information included intraoperative transfusion, intraoperative blood loss, intraoperative warming time of transfusion, operative time, anesthesia time, recovery room to extubation time, post-anesthesia care unit (PACU) stay time, postoperative flatulence, loss of blood, reoperation due to bleeding, hospitalization days, and medical expenses.

Patient\'s nasopharyngeal temperature was measured using the Carefusion Temperature Probe (400 Series, GE Healthcare, USA) with the Carescape Monitor B650, GE Healthcare) during the whole perioperative period. Biochemical examination results including coagulation function indexes (prothrombin time activated partial thromboplastin time, thrombin time), fibrinogen; white blood cell, platelet, total bilirubin, pH, glucose, lactose were collected during the perioperative period.

Postoperative complications including cold shivering, pneumonia, pulmonary embolism, urinary fistula, and intestinal obstruction were recorded. All data was compared between the two groups.

Statistical analysis
--------------------

Continuous variables were presented as mean±SD (standard deviation) while categorical data were indicated by number and percentage (%). Student\'s independent t-test was used to compare the differences between groups. If normality of continuous variables was not assumed, median (range) and non-parametric analysis Mann-Whitney U test would be used instead. Chi-square test and Fisher\'s exact test (if any expected value lower than 5 was observed) were used for categorical data. Two-way mixed design ANOVA was used to test the significance of main effect (time, group) and interaction effect (time\*group). Univariate and multivariate linear regression models were used to investigate the significance of group factor to the differences between pre/peri-operative and postoperative index. A *p*-value lower than 0.05 would be recognized as reaching significance of each test. All analyses were performed using IBM SPSS Version 20 (SPSS Statistics V20, IBM Corporation, Somers, New York).

RESULTS
=======

Demographic and clinical characteristics
----------------------------------------

A total of 108 patients (mean age= 62.20±11.05 years, range: 26-87, 82.41% male) undergoing DaVinci assisted laparoscopic radical cystectomy were enrolled, and randomly divided into the warming group (n=53) and control group (n=55). There was no significant difference in demographic and clinical characteristics between the warming and control groups (all *p*\>0.05, [Table 1](#t01){ref-type="table"}).

Perioperative information
-------------------------

The perioperative information was compared between the two groups. As shown in [Table 2](#t02){ref-type="table"}, the warming group had significantly less intraoperative transfusion (*p*=0.028) and shorter hospitalization days (both postoperative and total hospitalization, *p*\<0.05) than the control group. However, there was no significant difference in perioperative blood loss, operative time, anesthesia time, time from entering recovery room to extubation, PACU stay time, time to postoperative flatulence, blood loss, reoperation due to bleeding, and medical expenses (all *p*\>0.05).

Change of body temperature during the perioperative period
----------------------------------------------------------

Patient\'s body temperature was recorded at preoperative, intraoperative and postoperative periods. As shown in [Table 3](#t03){ref-type="table"}, during the entire intraoperative period (from 1 to 6h), the warming group had significantly higher body temperature than the control group (all *p*\<0.05). No significance was found in preoperative and recovery room periods (*p*\>0.05). At day 3 after the operation, the body temperature was slightly but significantly higher in control group than in the warming group (*p*\<0.05).

Perioperative laboratory results
--------------------------------

Laboratory results were compared between groups. There were significant differences in preoperative FIB, white blood cell, total bilirubin; intraoperative lactose; and postoperative thrombin time (TT) between the control and warming groups (all *p*\<0.05, [Table 4](#t04){ref-type="table"}). The difference between pre- and postoperative TT was also different between groups (*p*=0.004, [Table 4](#t04){ref-type="table"}).

Linear regression was used to investigate the effect of group factor on the differences between preoperative/intraoperative and postoperative results. The multivariate model was controlled with patient\'s age, gender, and ASA classification. The result showed that TT was the only significant factor ([Table 5](#t05){ref-type="table"}), suggesting that the warming group had lower TT level than the control group.

Postoperative complications
---------------------------

There was no significant difference in postoperative complications between the two groups, including cold shivering in the recovery room, pneumonia, pulmonary embolism, urinary fistula, and intestinal obstruction ([Table 6](#t06){ref-type="table"}, all *p*\>0.05).

DISCUSSION
==========

Under normal physiological conditions, the body core temperature fluctuates only within a narrow range (about ±0.2°C), while under anesthesia, the range is significantly increased to ±4°C [@B19]. In addition, body temperature under anesthesia is more easily affected by external factors. Robot-assisted laparoscopic radical cystectomy increases the overall operating time and requires prolonged anesthesia [@B06]. Most of the patients receiving radical cystectomy are elderly and are therefore more likely to develop perioperative hypothermia than young patients due to the degeneration of their body homeostasis ability. Therefore, maintaining normothermia is an important measure to reduce perioperative complications.

At present, intraoperative temperature maintaining devices include forced-air warming blankets, heating mattresses, circulating-water garment systems [@B20], and fluid warming system [@B16]. The disadvantage of warming blankets and heating mattresses is that the temperature sensor of elderly patients may degenerate, which may cause burns or thermal hypersensitivity. Water in circulating-water garment systems is considered as a potential source of pathogen contamination in hospitals and can be a source of infection if not properly maintained. The fluid warming system supplies heat by inserting the infusion catheter into the metal heating plate without circulating water. Constant-temperature fluids or blood can be delivered into every part of the body. Choi et al. have demonstrated that intravenous fluid warming can effectively maintain intraoperative normothermia in patients undergoing laparoscopic colorectal surgery [@B16]. However, the effectiveness of warming intravenous fluid has not been evaluated in robotic-assisted laparoscopic surgery.

In this study, we investigated the efficacy of fluid warming in elderly patients undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy. The results showed that during the entire intraoperative period, body temperature was significantly higher in the warming group than in the control group. Especially at 6h after surgery start, the core temperature dropped to 34.9°C in the control group but still maintained at 36.01°C in the warming group. This data suggested that our fluid warming protocol can effectively maintain normothermia during operation, which is consistent with the results of the studies conducted in laparoscopic colorectal surgery [@B16].

In the current study, the warming group had significantly less intraoperative transfusion than the control group, suggesting that fluid warming can significantly reduce intraoperative transfusion requirement. This finding is in line with the results of a meta-analysis, including 10 studies by Rajagopalan et al., which shows that mild hypothermia (decrease by \<1°C) significantly increases blood loss by approximately 16% and increases transfusion risk by 22% [@B21]. By contrast, maintaining intraoperative normothermia can effectively reduce blood loss and transfusion requirement [@B21]. However, although the intraoperative blood loss was less in the warming group than in the control group (141.13±108.82 *vs*. 212.73±525.31 mL) in our study, the difference did not reach statistical significance. One possible explanation might be that the advantages of reducing blood loss by fluid warming may be reduced in robotic-assisted laparoscopic surgery.

Intraoperative hypothermia has been shown to reduce the level of circulating platelets and platelets function [@B21],[@B22]. Supporting this notion, our study showed that the warming group had a higher postoperative platelet count compared with the control group. On the other hand, we observed that the warming group had significantly shorter postoperative TT than the control group. Multivariate linear regression analysis confirmed that the warming group had shorter TT than the control group, suggesting that fluid warming can improve the postoperative coagulation function. Intraoperative hypothermia is known to induce coagulopathy by impairing several enzymes of the coagulation cascade, eventually reducing clot formation [@B07]. Both impaired function of platelets and coagulation can lead to increase bleeding time and intraoperative blood loss.

Yi et al. conducted a national cross-sectional study in China on 3,132 patients under general anesthesia, and the results demonstrate that intraoperative hypothermia would increase intensive care unit (ICU) admissions and prolonged hospitalization days [@B23]. Kurz et al. have demonstrated that maintaining normothermia intraoperatively by combining intravenous fluids warming and forced-air cover can effectively decrease the incidence of infectious complications and hospitalization days [@B15]. In agreement with these observations, our study also found that compared to the control group, the warming group had shorter hospitalization days. This observation indicated that fluid warming can promote postoperative recovery.

CONCLUSIONS
===========

In summary, this study demonstrated that fluid warming can effectively reduce transfusion requirement and hospitalization days, maintain intraoperative normothermia and promote postoperative coagulation function in elderly patients undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy, which is worth further clinical application.
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###### 

Demographic and clinical characteristics.

  Parameters                                            Control (n=55)   Warming (n=53)   Total (n=108)   *p*
  ----------------------------------------------------- ---------------- ---------------- --------------- -------
  Sex                                                                                                     0.240
  Male                                                  43 (78.18)       46 (86.79)       89 (82.41)      
  Female                                                12 (21.82)       7 (13.21)        19 (17.59)      
  Age, years                                            63.55±10.38      60.81±11.65      62.20±11.05     0.155
  ASA classification                                                                                      0.124
  II                                                    23 (41.82)       30 (56.60)       53 (49.07)      
  III                                                   32 (58.18)       23 (43.40)       55 (50.93)      
  Cardiac function[a](#TFN02t01){ref-type="table-fn"}   0.66±0.06        0.66±0.05        0.66±0.06       0.850
  BMI                                                   23.04±3.20       23.44±2.83       23.24±3.02      0.545

ASA, American Society of Anesthesiologists; BMI, Body Mass Index.

Cardiac function was assessed by determining the ejection fraction (EF).

###### 

Patient's operative information.

  Parameters                                        Control (n=55)                   Warming (n=53)                   Total (n=108)                    *p*
  ------------------------------------------------- -------------------------------- -------------------------------- -------------------------------- ---------
  Intraoperative transfusion, ml                    2153.64±671.91                   1903.30±491.32                   2030.79±600.80                   0.028
  Intraoperative blood loss, ml                     212.73±525.31                    141.13±108.82                    177.59±382.50                    0.193
  Intraoperative warming time of transfusion, min   \-                               336.43±88.91                     336.43±88.91                     \-
  Operative time, min                               346.51±94.85                     322.57±81.29                     334.76±88.86                     0.190
  Anesthesia time, min                              507.38±104.83                    476.68±93.28                     492.31±100.06                    0.132
  Recovery room to extubation time, min             26.39±12.70                      26.62±14.31                      26.50±13.44                      0.909
  PACU stay time, min                               70.17±19.55                      75.91±27.84                      72.90±23.90                      0.410
  Postoperative flatulence, day                     3.71±1.71                        3.70±1.39                        3.70±1.55                        0.768
  Loss of blood, ml                                                                                                                                    
  Operative day                                     429.42±214.71                    431.32±164.92                    430.35±191.01                    0.268
  Day 1 after surgery                               434.04±274.84                    421.36±181.62                    427.81±232.79                    0.683
  Day 2 after surgery                               326.73±203.61                    313.72±180.74                    320.34±191.94                    0.822
  Day 3 after surgery                               300.27±269.22                    312.06±271.74                    305.83±269.16                    0.718
  Reoperation due to bleeding                                                                                                                          0.580
  No                                                53 (96.36)                       52 (98.11)                       105 (97.22)                      
  Yes                                               2 (3.64)                         1 (1.89)                         3 (2.78)                         
  Hospitalization, days                                                                                                                                
  Postoperative                                     20 (5-75)                        16 (5-48)                        18 (5-75)                        \<0.001
  Total                                             34.07±10.87                      23.62±6.82                       28.94±10.48                      \<0.001
  Medical expenses                                                                                                                                     
  Anesthesia                                        12056.21 (9285.64-23325.39)      12861.46 (7923.50-19068.38)      12478.44 (7923.50-23325.39)      0.557
  Total                                             107026.61 (79421.88-359872.75)   103629.18 (82531.73-183466.73)   105198.58 (79421.88-359872.75)   0.823

PACU; post-anesthesia care unit.

###### 

Change in the patient's body temperature during the perioperative period.

  Parameters         Control (n=55)   Warming (n=53)   Total (n=108)   *p*
  ------------------ ---------------- ---------------- --------------- ---------
  Preoperative       36.45±0.36       36.48±0.35       36.47±0.35      0.641
  Intraoperative                                                       
  1 hour             36.05±0.42       36.22±0.47       36.13±0.45      0.036
  2 hours            35.80±0.39       36.14±0.45       35.97±0.45      \<0.001
  3 hours            35.54±0.44       36.10±0.40       35.81±0.50      \<0.001
  4 hours            35.27±0.39       36.09±0.39       35.67±0.56      \<0.001
  5 hours            35.06±0.34       36.12±0.30       35.55±0.62      \<0.001
  6 hours            34.90±0.30       36.01±0.33       35.29±0.62      \<0.001
  Postoperative                                                        
  In recovery room   36.25±0.38       36.12±0.38       36.19±0.38      0.103
  Back to the ward   36.42±0.37       36.47±0.39       36.44±0.38      0.564
  Day 1              37.07±0.44       36.95±0.43       37.01±0.44      0.160
  Day 2              36.92±0.42       36.87±0.32       36.89±0.37      0.310
  Day 3              36.93±0.54       36.74±0.30       36.84±0.45      0.024

###### 

Laboratory results during perioperative period.

  Parameters                                                 Control (n=55)   Warming (n=53)   Total (n=108)   *p*
  ---------------------------------------------------------- ---------------- ---------------- --------------- -------
  Preoperative                                                                                                 
  PT                                                         11.83±0.82       11.61±0.92       11.72±0.87      0.121
  APTT                                                       25.59±4.33       25.34±4.00       25.46±4.15      0.907
  TT                                                         18.23±2.82       17.32±1.86       17.78±2.43      0.080
  FIB                                                        3.78±2.92        3.07±1.17        3.43±2.25       0.034
  WBC                                                        6.51±2.06        7.78±2.90        7.14±2.58       0.023
  Platelet                                                   229.96±59.78     259.09±71.17     244.26±66.92    0.056
  Total bilirubin                                            13.36±4.91       11.13±3.93       12.27±4.58      0.012
  Intraoperative (average)                                                                                     
  PH                                                         7.31±0.06        7.33±0.05        7.32±0.06       0.210
  GUL                                                        6.27±1.12        6.26±1.13        6.27±1.12       0.875
  LAC                                                        0.69±0.20        0.85±0.39        0.77±0.31       0.016
  Postoperative                                                                                                
  PT                                                         15.44±13.46      12.33±0.89       13.99±9.91      0.069
  APTT                                                       30.41±9.21       27.14±4.84       28.89±7.62      0.245
  TT                                                         17.84±5.19       15.72±1.48       16.85±4.04      0.010
  FIB                                                        3.67±1.40        3.32±0.99        3.50±1.23       0.450
  WBC                                                        11.05±4.30       12.22±4.12       11.62±4.24      0.219
  Platelet                                                   187.91±53.33     229.83±67.46     208.48±63.95    0.002
  Total bilirubin                                            14.26±5.90       13.59±6.81       13.93±6.34      0.378
  pH                                                         7.34±0.04        7.35±0.04        7.35±0.04       0.084
  GUL                                                        7.18±1.75        7.10±1.98        7.14±1.85       0.453
  LAC                                                        1.18±0.68        1.25±0.69        1.21±0.68       0.414
  Difference between preoperative and postoperative period                                                     
  PT                                                         3.50±13.40       0.66±1.13        2.18±9.86       0.156
  APTT                                                       4.14±6.30        1.53±3.89        2.93±5.43       0.127
  TT                                                         0.26±4.44        -2.14±2.42       -0.86±3.81      0.004
  Fibrinogen                                                 0.24±1.23        0.46±1.39        0.35±1.30       0.457
  WBC                                                        4.53±4.33        4.43±3.67        4.48±4.01       0.939
  Platelet                                                   ++               -29.26±36.51     -35.78±36.56    0.161
  Total bilirubin                                            0.89±5.58        2.46±5.83        1.66±5.73       0.265
  pH                                                         0.03±0.06        0.02±0.05        0.03±0.05       0.887
  Glucose                                                    0.87±1.48        0.85±1.54        0.86±1.50       0.430
  Lactose                                                    0.48±0.69        0.42±0.65        0.46±0.67       0.958

PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; WBC, white blood cell; Platelet; pH.

###### 

Univariate and multivariate linear regression results.

                    Linear regression                                     
  ----------------- ---------------------- ------- ---------------------- -------
  PT                -2.84 (-8.03-2.34)     0.277   -3.11 (-8.72-2.51)     0.272
  APTT              -2.61 (-5.42-0.19)     0.067   -1.59 (-4.37-1.20)     0.259
  TT                -2.40 (-4.32\--0.48)   0.015   -2.46 (-4.47\--0.44)   0.018
  Fibrinogen        0.22 (-0.47-0.92)      0.522   0.30 (-0.45-1.05)      0.426
  WBC               -0.10 (-1.63-1.44)     0.900   -0.08 (-1.64-1.48)     0.920
  Platelet          12.79 (-1.01-26.59)    0.069   11.17 (-2.83-25.17)    0.117
  Total bilirubin   1.57 (-0.61-3.74)      0.156   1.53 (-0.71-3.77)      0.178
  pH                0.00 (-0.03-0.02)      0.743   0.00 (-0.03-0.02)      0.871
  Glucose           -0.02 (-0.65-0.61)     0.952   0.03 (-0.63-0.68)      0.935
  Lactose           -0.06 (-0.34-0.22)     0.677   0.00 (-0.29-0.28)      0.975

PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; WBC, white blood cell; Platelet; pH.

###### 

Postoperative complications.

  Parameters                     Control (n=55)   Warming (n=53)   Total (n=108)   *p*
  ------------------------------ ---------------- ---------------- --------------- -------
  Cold shiver in recovery room                                                     0.282
      No                         38 (70.37)       39 (79.59)       77 (74.76)      
      Yes                        16 (29.63)       10 (20.41)       26 (25.24)      
  Pneumonia                                                                        0.963
      No                         52 (94.55)       50 (94.34)       102 (94.44)     
      Yes                        3 (5.45)         3 (5.66)         6 (5.56)        
  Pulmonary embolism                                                               \-
      No                         55 (100.00)      53 (100.00)      108 (100.00)    
      Yes                        0                0                0               
  Urinary fistula                                                                  0.687
      No                         39 (70.91)       35 (67.31)       74 (69.16)      
      Yes                        16 (29.09)       17 (32.69)       33 (30.84)      
  Intestinal obstruction                                                           0.378
      No                         37 (67.27)       39 (75.00)       76 (71.03)      
      Yes                        18 (32.73)       13 (25.00)       31 (28.97)      
